Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
Bergmann MW, Ince H, Kische S, Schmitz T, Meincke F, Schmidt B, Foley D, Betts TR, Grygier M, Protopopov AV, Stein KM, Boersma LVA. Bergmann MW, et al. Among authors: grygier m. EuroIntervention. 2018 Apr 20;13(17):2003-2011. doi: 10.4244/EIJ-D-17-00672. EuroIntervention. 2018. PMID: 29313819 Free article.
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
Boersma LV, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts T, Mazzone P, Foley D, Grygier M, Sievert H, De Potter T, Vireca E, Stein K, Bergmann MW; following investigators and institutions participated in the EWOLUTION study. Boersma LV, et al. Among authors: grygier m. Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006841. doi: 10.1161/CIRCEP.118.006841. Circ Arrhythm Electrophysiol. 2019. PMID: 30939908 Free article.
Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN.
Ledwoch J, Sievert K, Boersma LVA, Bergmann MW, Ince H, Kische S, Pokushalov E, Schmitz T, Schmidt B, Gori T, Meincke F, Protopopov AV, Betts TR, Mazzone P, Foley D, Grygier M, De Potter T, Sievert H; EWOLUTION Investigators. Ledwoch J, et al. Among authors: grygier m. Europace. 2020 Jul 1;22(7):1036-1043. doi: 10.1093/europace/euaa074. Europace. 2020. PMID: 32464648
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
Cruz-González I, Korsholm K, Trejo-Velasco B, Thambo JB, Mazzone P, Rioufol G, Grygier M, Möbius-Winkler S, Betts T, Meincke F, Sandri M, Schmidt B, Schmitz T, Nielsen-Kudsk JE. Cruz-González I, et al. Among authors: grygier m. JACC Cardiovasc Interv. 2020 Dec 14;13(23):2732-2741. doi: 10.1016/j.jcin.2020.06.056. Epub 2020 Nov 11. JACC Cardiovasc Interv. 2020. PMID: 33189641 Free article.
Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
Sedaghat A, Nickenig G, Schrickel JW, Ince H, Schmidt B, Protopopov AV, Betts TR, Gori T, Sievert H, Mazzone P, Grygier M, Wald C, Vireca E, Allocco D, Boersma LVA; EWOLUTION study group. Sedaghat A, et al. Among authors: grygier m. Catheter Cardiovasc Interv. 2021 Jun 1;97(7):E1019-E1024. doi: 10.1002/ccd.29458. Epub 2021 Jan 8. Catheter Cardiovasc Interv. 2021. PMID: 33417282
Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience.
Armario X, Rosseel L, Kharbanda R, Khogali S, Abdel-Wahab M, Van Mieghem NM, Tchétché D, Dumonteil N, De Backer O, Cotton J, McGrath B, Balakrishnan D, Ali N, Farhan S, Joseph J, Charbonnier G, Okuno T, McHugh F, Hildick-Smith D, Gilgen N, Hokken T, Spence MS, Frerker C, Angelillis M, Grygier M, Cockburn J, Bjursten H, Jeger RV, Teles R, Petronio AS, Pilgrim T, Sinning JM, Nickenig G, Søndergaard L, Blackman DJ, Mylotte D. Armario X, et al. Among authors: grygier m. JACC Cardiovasc Interv. 2021 Jan 25;14(2):172-181. doi: 10.1016/j.jcin.2020.09.044. Epub 2020 Nov 25. JACC Cardiovasc Interv. 2021. PMID: 33478633 Free article.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.
Potpara T, Grygier M, Häusler KG, Nielsen-Kudsk JE, Berti S, Genovesi S, Marijon E, Boveda S, Tzikas A, Boriani G, Boersma LVA, Tondo C, De Potter T, Lip GYH, Schnabel RB, Bauersachs R, Senzolo M, Basile C, Bianchi S, Osmancik P, Schmidt B, Landmesser U, Döhner W, Hindricks G, Kovac J, Camm AJ. Potpara T, et al. Among authors: grygier m. Europace. 2024 Mar 30;26(4):euae035. doi: 10.1093/europace/euae035. Europace. 2024. PMID: 38291925 Free PMC article.
225 results